SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 88 filers reported holding SYNAGEVA BIOPHARMA CORP in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $1,137,242,000 | +15.0% | 11,660,432 | +9.4% | 9.46% | -6.3% |
| Q4 2014 | $989,182,000 | +34.9% | 10,660,432 | 0.0% | 10.10% | +9.3% |
| Q3 2014 | $733,225,000 | -34.4% | 10,660,432 | 0.0% | 9.23% | -32.5% |
| Q2 2014 | $1,117,213,000 | +26.5% | 10,660,432 | +0.1% | 13.68% | +21.9% |
| Q1 2014 | $883,480,000 | +32.9% | 10,648,182 | +3.7% | 11.23% | +19.8% |
| Q4 2013 | $664,880,000 | +2.1% | 10,273,182 | 0.0% | 9.37% | +1.2% |
| Q3 2013 | $651,238,000 | +68.2% | 10,273,182 | +11.4% | 9.26% | +20.9% |
| Q2 2013 | $387,189,000 | – | 9,223,182 | – | 7.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 11,660,432 | $1,137,242,000 | 9.46% |
| BB BIOTECH AG | 1,025,476 | $100,015,000 | 2.98% |
| EMORY UNIVERSITY | 9,854 | $961,000 | 1.82% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 3,245,542 | $316,538,000 | 1.72% |
| New Leaf Venture Partners, L.L.C. | 24,379 | $2,378,000 | 1.61% |
| Alpha Wave Global, LP | 304,000 | $29,649,000 | 1.46% |
| Opus Point Partners Management, LLC | 17,700 | $1,726,000 | 1.45% |
| SECTORAL ASSET MANAGEMENT INC | 365,684 | $35,665,000 | 1.35% |
| Pier Capital, LLC | 61,028 | $5,952,000 | 0.90% |
| Tekla Capital Management LLC | 198,689 | $19,378,000 | 0.77% |